Subscribe to Dr. Mirkin's free FITNESS & HEALTH NEWSLETTER
HDL CHOLESTEROL PREVENTS HEART ATTACKS

People who have blood levels of the good HDL cholesterol below 35 are at increased risk for heart attacks, and raising HDL cholesterol helps to prevent them.

The bad LDL cholesterol causes heart attacks by depositing cholesterol into arteries to form plaques. The good HDL cholesterol prevents heart attacks by carrying cholesterol to the liver and preventing the bad LDL cholesterol from being oxidized to form plaques. People with low HDL levels often have high blood triglyceride levels, usually are carbohydrate insensitive, not particularly fat sensitive, and therefore, should reduce their intake of sugar, bakery products and pastas and other sources of refined carbohydrates. The vitamin, niacin, may be the first choice drug to raise blood levels of HDL cholesterol because it appears to be more effective than other drugs, rarely interferes with the use of other drugs, and is very inexpensive.

1) The metabolic pathways of high-density lipoprotein, low-density lipoprotein, and triglycerides: A current review. PO Kwiterovich. American Journal of Cardiology, 2000, Vol 86, Iss 12A, Sp. Iss. SI, pp 5L-10L

2) The epidemiology of low levels of high-density lipoproteins cholesterol in patients with and without coronary artery disease. DJ Maron. American Journal of Cardiology, 2000, Vol 86, Iss 12A, Sp. Iss. SI, pp 11L-14L.

3) High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: Assessing the data from Framingham to the Veterans Affairs high-density lipoprotein intervention trial. WE Boden. American Journal of Cardiology, 2000, Vol 86, Iss 12A, Sp. Iss. SI, pp 19L-22L.

4) Raising high-density lipoprotein cholesterol and lowering low-density lipoprotein cholesterol as adjunctive therapy to coronary artery revascularization. ER Bates. American Journal of Cardiology, 2000, Vol 86, Iss 12A, Sp. Iss. SI, pp 28L-34L.

5) The pharmacokinetics and pharmacodynamics of agents proven to raise high-density lipoprotein cholesterol. RW Piepho. American Journal of Cardiology, 2000, Vol 86, Iss 12A, Sp. Iss. SI, pp 35L-40L.

6) Nonpharmacologic management of low levels of high-density lipoprotein cholesterol. HN Ginsberg. American Journal of Cardiology, 2000, Vol 86, Iss 12A, Sp. Iss. SI, pp 41L-45L. 7) Raising high-density lipoprotein cholesterol with niacin and fibrates: A comparative review. DL Sprecher. American Journal of Cardiology, 2000, Vol 86, Iss 12A, Sp. Iss. SI, pp 46L-50L.

8) Evaluating niacin in its various forms. RH Knopp. American Journal of Cardiology, 2000, Vol 86, Iss 12A, Sp. Iss. SI, pp 51L-56L.

9) Divergent approaches to the treatment of dyslipidemia with low levels of high-density lipoprotein cholesterol. TA Pearson. American Journal of Cardiology, 2000, Vol 86, Iss 12A, Sp. Iss. SI, pp 57L-61L.

10) Clinical treatment of dyslipidemia: Practice patterns and missed opportunities. SC Smith. American Journal of Cardiology, 2000, Vol 86, Iss 12A, Sp. Iss. SI, pp 62L-65L.

Checked 8/31/05

May 21st, 2013
|   Share this Report!

About the Author: Gabe Mirkin, MD

Sports medicine doctor, fitness guru and long-time radio host Gabe Mirkin, M.D., brings you news and tips for your healthful lifestyle. A practicing physician for more than 50 years and a radio talk show host for 25 years, Dr. Mirkin is a graduate of Harvard University and Baylor University College of Medicine. He is board-certified in four specialties: Sports Medicine, Allergy and Immunology, Pediatrics and Pediatric Immunology. The Dr. Mirkin Show, his call-in show on fitness and health, was syndicated in more than 120 cities. Read More
Copyright 2016 Drmirkin | All Rights Reserved | Powered by Xindesigns